Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

C1Q COMPONENT COMPLEMENT - ANVISA Registration 81357320083

Access comprehensive regulatory information for C1Q COMPONENT COMPLEMENT in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81357320083 and manufactured by THE BINDING SITE GROUP LTD. The registration is held by THE BINDING SITE BRASIL COMERCIO DE PRODUTOS PARA LABORATORIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, THE BINDING SITE GROUP LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
4 Competitors
5 Recent Registrations
81357320083
Registration Details
ANVISA Registration Number: 81357320083
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Human Complement C1q NL Bindarid Kit
Risk Class II

Registration Details

81357320083

25351265188201818

23119193000108

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

May 21, 2018

VIGENTE

09/18/2025 19:00:01